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Abstract — Aim: Chronic cigarette smoking appears to adversely affect several domains of neurocognition in those with alcohol
use disorders (AUDs). The primary goal of this study was to identify which measures commonly used to assess neurocognition in
AUDs accurately predict smoking status of individuals seeking treatment of alcohol dependence. Methods: Treatment-seeking
alcohol-dependent participants (ALC; n=92) completed a comprehensive neuropsychological battery after 33±9 days of abstinence.
Measures signiﬁcantly different between smoking and non-smoking ALC were entered as predictors in binary logistic regression and
discriminant analysis models, with smoking status as the dependent variable. Results: Smoking ALC performed signiﬁcantly worse
than non-smoking ALC on measures assessing processing speed, auditory–verbal and visuospatial learning and memory. Using these
measures as predictors, a logistic regression model accurately classiﬁed 91% of smokers and non-smokers into their respective
groups overall and accounted for 68% of the variance in smoking status. The discriminant analysis conﬁrmed the ﬁndings from the
logistic regression. In smoking ALC, smoking chronicity was inversely related to performance on multiple measures after controlling
for lifetime alcohol consumption. Conclusions: Measures of processing speed, learning and memory robustly predicted the smoking
status of ALC with high sensitivity and speciﬁcity during early abstinence. The results identiﬁed speciﬁc measures within a compre-
hensive neurocognitive battery that discriminated smoking and non-smoking alcohol-dependent individuals with a high sensitivity
and speciﬁcity. The association of greater smoking chronicity and poorer performance on multiple measures after control for alcohol
consumption suggests that chronic smoking adds an additional burden to neurocognitive function in those with alcohol dependence.
INTRODUCTION
Considerable variability exists in the type and magnitude of
neurocognitive abnormalities exhibited by individuals with
alcohol use disorders (AUDs) following detoxiﬁcation
(Oscar-Berman, 2000; Rourke and Loberg, 1996; Sher et al.,
2005). Comorbid behaviors/conditions such as chronic
smoking in AUDs may contribute to this variability in neuro-
cognition. Approximately 60–90% of individuals in North
America seeking treatment for AUDs are chronic smokers
(Durazzo and Meyerhoff, 2007; Room, 2004). Our group
(Durazzo et al., 2006b, 2008) and others (Friend et al., 2005;
Glass et al., 2006, 2009) found that chronic cigarette
smoking among individuals with an AUD is associated with
adverse effects on multiple neurocognitive domains of func-
tioning, in particular executive skills, learning and memory,
processing speed and cognitive efﬁciency. These studies
(Durazzo et al., 2006b, 2008) also showed that not all
aspects of neurocognition (e.g. visuospatial skills, working
memory) are necessarily modulated by chronic smoking in
those with an AUD.
To better understand the scope and magnitude of the neu-
rocognitive consequences associated with chronic smoking
in AUDs, we have employed a neurocognitive battery com-
posed of common clinical and research measures to compre-
hensively assess the domains of functioning reported to be
adversely affected by both AUDs (Oscar-Berman, 2000) and
comorbid chronic smoking (Swan and Lessov-Schlaggar,
2007). The primary goal of this study was to identify individ-
ual measures in our battery that can be combined to parsimo-
niously and speciﬁcally discriminate smoking from
non-smoking alcohol-dependent individuals, rather than
strictly examining for mean differences between smokers and
non-smokers across general domains of function (e.g. visuos-
patial skills, working memory) or use smoking status as a
predictor of general domain function. Identiﬁcation of the
speciﬁc measures that predict smoking status may provide
more precise information on the nature and magnitude of
neurocognitive consequences associated with chronic
smoking in AUDs. This approach also permits examination
of the sensitivity and speciﬁcity of the measures used to
predict smoking status, which is not possible when utilizing
standard parametric linear methods. Finally, identiﬁcation of
the speciﬁc measures that accurately and uniquely discrimi-
nate smokers and non-smokers can be used to determine
whether the ‘hallmark’ neurocognitive proﬁle associated with
chronic smoking in this AUD cohort is reproducible in inde-
pendent samples. Such replication studies are imperative to
ensure that previous ﬁndings (e.g. Durazzo et al., 2006a,b,
2008) are generalizable to the larger population of treatment-
seeking AUDs. A secondary goal of this study was to
explore the relationships between the measures of smoking
chronicity and the performance on individual neurocognitive




Individuals seeking treatment for AUDs (n=92; four
females) were recruited from the VA Medical Center
Substance Abuse Day Hospital and the Kaiser Permanente
Chemical Dependence Recovery Program outpatient clinics
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28 and 68 at the time of study, and all met the diagnostic
and statistical manual of mental disorders - fourth edition
(DSM-IV) criteria for alcohol dependence (95% with physio-
logical dependence). The alcohol-dependent participants
(ALC) completed a comprehensive neuropsychological asses-
sment battery after 33 ±9 days of sustained abstinence. There
was no difference between smoking (sALC; n=56) and non-
smoking (nsALC; n =36) alcohol-dependent individuals in
the duration of abstinence prior to assessment. All sALC
were actively smoking at the time of assessment. No sALC
appreciably changed their cigarette consumption from the
onset of abstinence to the time of assessment. Eight nsALC
reported a previous history of chronic smoking, with ﬁve
quitting more than 8 years and three more than 3 years prior
to enrollment. The performance of the former smokers was
within ±0.5 standard deviations of the nsALC group mean
across measures. Demographics, indices of alcohol consump-
tion, smoking severity, depressive and anxiety symptomatol-
ogy and frequency of medical, psychiatric and substance use
comorbidities for sALC and nsALC are given in Table 1.
Primary inclusion criteria were current DSM-IV diagnosis
of alcohol dependence or abuse (American Psychiatric
Association, 1994), ﬂuency in English, consumption of more
than 150 alcoholic drinks per month (one alcoholic drink
equivalent = 13.6 g pure ethanol) for at least 8 years prior to
enrollment for men, and consumption of more than 80
drinks per month for at least 6 years prior to enrollment for
women. Primary exclusion criteria are fully detailed in our
previous work (Durazzo et al., 2004). In brief, no participant
had a history of a neurologic (e.g. non-alcohol-related
seizure disorder, neurodegenerative disorder, demyelinating
disorder), general medical (e.g. myocardial infarction, type-1
diabetes, cerebrovascular accident) or psychiatric (i.e. schizo-
phrenia spectrum, bipolar disorder, post-traumatic stress dis-
order) conditions known or suspected to inﬂuence
neurocognition. The following comorbidities were permitted
in ALC participants due to their prevalence in AUDs
(Gilman and Abraham, 2001; Stinson et al., 2005): hepatitis
C, type-2 diabetes, hypertension, unipolar mood (major
depression, substance-induced mood disorder) and anxiety
disorders (generalized anxiety disorder, panic disorder).
ALC who met DSM-IV criteria for current or past substance
abuse, and past substance dependence that occured at least
ﬁve prior to enrollment were also included. Current opioid
replacement therapy (e.g. methadone) was exclusionary.
Medical, psychiatric, substance and drinking history
assessment
Participant medical history was obtained from self-report
and conﬁrmed or amended via available medical records.
Participants completed the Structured Clinical Interview for
DSM-IV Axis I disorders, Patient Edition, Version 2.0
(SCID-I/P; First et al., 1998), and standardized question-
naires assessing lifetime (LT) alcohol consumption [lifetime
drinking history (LDH); Skinner and Sheu, 1982] and sub-
stance use (in-house questionnaire assessing substance type,
and quantity and frequency of use). From the LDH, we
derived the average number of drinks per month over 1, 3 and
8 years prior to enrollment, average number of drinks per
month over LT, number of LT years of regular drinking (i.e.
duration for which the participant began consuming at least
one alcoholic drink per month), number of months of heavy
drinking (i.e. total number of months over LT in which the
participant drank in excess of 100 drinks per month) and age
of onset of heavy drinking. All participants completed self-
report measures of depressive [Beck Depression Inventory
(BDI); Beck, 1978] and anxiety symptomatology [State-Trait
Anxiety Inventory (STAI), form Y-2; Spielberger et al., 1977]
and nicotine dependence [Fagerstrom Tolerance Test for
Nicotine Dependency (FTND); Fagerstrom et al., 1991]. The
total number of cigarettes currently smoked per day and the
number of years of smoking at the current level were also
recorded and pack years [i.e. (number of cigarettes per day/
20) ×number of years of smoking at level reported at enroll-
ment] were calculated for sALC.
Neuropsychological assessment
Participants completed a comprehensive battery, which eval-
uated neurocognitive and motor functions adversely affected
by alcohol dependence (Oscar-Berman, 2000; Rourke and
Table 1. Demographics, alcohol and cigarette use histories, self-report questionnaires and comorbidity frequency for nsALC and sALC (mean±SD)
Measure nsALC (n=36) sALC (n=56)
Age (years) 52.1±9.8 (min=31; max=68) 50.1±8.9 (min=28; max=68)
Education (years) 14.3±2.3 (min=10; max=19) 13.5±2.0 (min=10; max=20)
% Caucasian 75 74
Number of days abstinent 32±10 (min=16; max=58) 33±9 (min=16; max=57)
Average drinks/month over past year 370±201 (min=96; max=920) 416±206 (min=106; max=920)
Lifetime average drinks/month 179±119 (min=69; max=532) 258±116* (min=90; max=543)
% with medical comorbidity 42 47
% with substance use disorder comorbidity 22 21
% with psychiatric comorbidity 53 41
FTND NA 6.2±3.9 (min=2; max=10)
Cigarettes per day NA 19.5±8.8 (min=5; max=50)
Pack years NA 29.1±20.1 (min=5; max=87.5)
Smoking duration (years) NA 26.2±12.4 (min=5; max=54)
BDI 7.7±8.1 (min=1; max=28) 10.8±7.6 (min=1; max=33)
STAI 43.1±11.0 (min=24; max=62) 43.8±10.9 (min=21; max=68)
BDI, Beck Depression Inventory; FTND, Fagerstrom Tolerance Test for Nicotine Dependence; Max, maximum; Min, minimum; NA, not applicable; STAI,
State-trait Anxiety Inventory—Trait.
*P<0.05.
508 Durazzo et al.Grant, 1999) and chronic cigarette smoking (Durazzo et al.,
2007; Swan and Lessov-Schlaggar, 2007). sALC were
allowed to smoke ad libitum prior to assessment and to take
smoke breaks during the assessment. The individual
measures that comprised our battery were as follows
(Table 2): Brief Visuospatial Memory Test-Revised
(Benedict, 1997), Total Recall and Delayed Recall;
California Verbal Learning Test-II (Delis et al., 2000),
Immediate Recall trials 1-5, Short and Long Delay Free
Recall; Grooved Pegboard Test (Lafayette Instrument,
Lafayette, IN, USA); Luria-Nebraska Item 99 (Golden et al.,
1978); Short Categories Test (Wetzel and Boll, 1987); Stroop
Color-Word Test (Golden, 1978); Trail Making Test, parts A
and B (Reitan and Wolfson, 1985); Wechsler Adult
Intelligence Scale, 3rd edn (WAIS-III) (Wechsler, 1997),
Arithmetic, Block Design, Digit Span, Digit Symbol,
Information, Picture Completion, and Similarities and
Symbol Search subtests; Wisconsin Card Sorting Test-64:
Computer Version 2-Research Edition (Heaton and Staff,
1993) total errors, non-perseverative errors, perseverative
errors and perseverative responses. Premorbid verbal intelli-
gence was estimated with the American National Adult
Reading Test (Grober and Sliwinski, 1991). For the
Luria-Nebraska Item 99, the number correct (maximum
possible =8) was divided by the time required to complete
the task. This ratio was used due to the low ceiling for the
number correct (i.e. most participants achieved a score of 6
or better) and the resultant highly skewed distribution.
Raw scores for all neurocognitive measures, except the
Luria-Nebraska Item 99 ratio, were converted to age-adjusted
standardized scores via the normative data accompanying the
particular measure (i.e. BVMT-R, CVLT-II, Short Categories
Test, Stroop Color-Word Test, WAIS-III subtests) or age and
education [WCST-64 variables; Trails A and B via Heaton
Compendium Norms (Heaton et al., 1991)]. Standardized
scores were transformed to z-scores for all measures. For the
Luria-Nebraska Item 99 ratio, raw scores were converted to
z-scores based on the performance of 30 non-smoking light
drinking controls, as there are no norms available for this
measure.
Data analyses
Independent sample t-tests were used to evaluate for differ-
ences between nsALC and sALC on all individual neurocog-
nitive measures, age, education, predicted premorbid IQ and
measures of alcohol consumption. Fisher’s exact test was
used to determine whether nsALC and sALC differed in the
frequency of comorbid medical conditions (primarily hyper-
tension and hepatitis C), psychiatric disorders (primarily uni-
polar mood and anxiety disorders) and substance abuse
(primarily psychostimulant and cannabis abuse). Although
sALC and nsALC were not signiﬁcantly different on age and
AMNART, these measures accounted for a signiﬁcant
amount of the variance in neurocognition in both nsALC
and sALC cohorts in our previous work (Durazzo et al.,
2008) and, therefore, were used as covariates in the present
study. Measures that were different between nsALC and
sALC at P <0.05 were entered as predictors in a binary
logistic regression model, with smoking status (i.e. nsALC
and sALC) as the dependent measure. In addition, a discri-
minant analysis, with smoking status as the grouping vari-
able, was also conducted with the same predictors used in
the binary logistic regression. The rationale for this analysis
was to seek conﬁrmation of our logistic regression-based
ﬁndings using a different method to predict the smoking
Table 2. Individual measure z-scores for nsALC and sALC (mean±SD)
Measure nsALC (n =36) sALC (n=56) Effect size (Cohen’s d)
AMNART 112.2±9.1 113.0±9.2 0.09
BVMT-R Total Recall −0.36±0.98 −0.90±1.07* 0.53
BVMT-R Delayed Recall −0.27±1.09 −0.78±1.12* 0.47
CVLT-II Immediate Recall (trials 1–5) 0.99±0.89 −0.04±0.98*** 1.10
CVLT-II Short Delayed Free Recall 0.63±0.88 −0.15±0.90*** 0.88
CVLT-II Long Delayed Free Recall 0.79±0.77 −0.23±0.94*** 1.17
Grooved Peg Board Dominant Hand −0.86±1.07 −0.92±0.96 0.06
Grooved Peg Board Non-Dominant Hand −0.94±0.85 −0.88±0.79 0.07
Luria Item 99 −0.81±0.98 −0.71±1.01 0.11
Short Categories Test −0.74±1.07 −0.69±1.15 0.05
Stroop Word −0.32±0.67 −0.53±0.56 0.35
Stroop Color −0.34±0.63 −0.69±0.59** 0.58
Stroop Color-Word −0.17±0.85 −0.68±0.97** 0.56
Trail Making Test, part A −0.16±0.93 −0.56±0.86* 0.46
Trail Making Test, part B −0.22±0.96 −0.34±0.93 0.13
WAIS-III Arithmetic −0.10±1.01 −0.27±0.81 0.19
WAIS-III Block Design 0.20±0.92 −0.04±0.90 0.26
WAIS-III Digit Span 0.15±0.88 0.25±0.92 0.11
WAIS-III Digit Symbol 0.02±0.77 −0.57±0.87*** 0.72
WAIS-III Information 0.55±0.87 0.55±0.86 0.00
WAIS-III Picture Completion 0.21±0.99 −0.36±0.84** 0.64
WAIS-III Similarities 0.91±1.00 0.59±1.00 0.32
WAIS-III Symbol Search 0.53±0.80 0.03±0.83** 0.62
WCST-64 Total Errors −0.30±1.03 −0.53±1.04 0.22
WCST-64 Perseverative Responses −0.22±0.82 −0.51±0.87 0.34
WCST-64 Perseverative Errors −0.30±0.87 −0.51±0.94 0.23
WCST-64 Non-Perseverative Errors −0.53±0.99 −0.58±0.98 0.05
Note: Asterisks indicate statistically significant differences (two-tailed t-test) between and nsALC and sALC, *P≤0.05, **P≤0.01, ***P≤0.001.
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percent of smokers accurately classiﬁed, whereas speciﬁcity
is the percent of non-smokers correctly classiﬁed.
To explore the relationships among the measures of
smoking chronicity and individual cognitive tests, we exam-
ined partial correlations, controlling for LT average drinks
per month, between LT number of years of smoking and the
individual measures comprising the battery. Total number
of years of smoking over LT was chosen as this measure of
smoking was most robustly related to several domains of
neurocognition in our previous work (Durazzo et al., 2006b).
Alpha levels (P ≤0.05) in these exploratory comparisons
were not corrected for multiplicity of tests. Factor analysis
(principle component analysis, varimax rotation) was con-
ducted with predictors used in the best-ﬁtting logistic
regression model to identify the latent functions assessed by
these factors. All analyses were completed with SPSS,
v17.0.
RESULTS
Participant performance on outcome measures
nsALC and sALC were not signiﬁcantly different on age,
education, average number of drinks per month 1 and 3
years prior to enrollment, self-report measures of depressive
(BDI) and anxiety symptomatology (STAI) or on the fre-
quency of comorbid medical, psychiatric disorders or sub-
stance misuse (Table 1). sALC performed signiﬁcantly
worse than nsALC on the following 11 measures: BVMT-R
Total Recall and Delayed Recall; CVLT-II Immediate Recall
(Trials 1–5), Short and Long Delayed Free Recall; Stroop
Color and Color-Word trials; Trail Making Test, Part A
(Trails A); WAIS-III Digit Symbol, Picture Completion and
Symbol Search subtests (Table 2). sALC consumed signiﬁ-
cantly more drinks per month over LT (LT average drinks;
P <0.05) than nsALC. These variables were entered into the
models described subsequently.
Prediction of group membership: logistic regression and
discriminant analysis
For the logistic regression analyses, we initially compared
the ﬁt accuracy and explanatory power in two primary
models. Model 1 included LT average drinks, age and
AMNART. In Model 2, the 11 individual neurocognitive
measures that were signiﬁcantly different between sALC and
nsALC (see above) were added to LT average drinks, age
and AMNART to determine whether the addition of the 11
neurocognitive measures provided an increased explanatory
power, ﬁt and classiﬁcation accuracy. Model 1, with LT
average drinks, age and AMNART as predictors, was signiﬁ-
cant [χ
2 (3) =12.77, P <0.005, r
2=0.18] and accurately
classiﬁed 50% of nsALC (i.e. speciﬁcity) and 83% of sALC
(i.e. sensitivity) into their respective groups, with an overall
classiﬁcation accuracy of 71%. This basic model accounted
for 18% of the variance in classiﬁcation of smoking status.
Model 2, which included the addition of the 11 neurocogni-
tive measures as predictors, was signiﬁcant [χ
2 (14)= 61.6,
P <0.001, r
2=0.68]. Model 2 accurately classiﬁed 86% of
nsALC and 95% of sALC into their respective groups, with
an overall classiﬁcation accuracy of 91% and accounted for
68% of the variance in classiﬁcation of smoking status.
Model 2, compared with Model 1, demonstrated signiﬁcantly
better ﬁt[ χ
2 (9)= 48.7, P<0.01], accounted for 50% more
variance in the group membership (68 vs. 18%) and demon-
strated a 20% better overall classiﬁcation accuracy (91 vs.
71%). The discriminant analysis using the variables included
in Model 2 was also signiﬁcant [χ
2 (14) =57.3, P <0.001],
and the combination of predictors accurately classiﬁed 91%
of nsALC and 86% of sALC, with an overall classiﬁcation
accuracy of 89%. Collinearity diagnostics indicated that all
predictors in the logistic regression model made unique con-
tributions to classiﬁcation of smoking status in the ALC
cohort.
To develop a potentially more parsimonious model, we
conducted a third binary logistic regression (Model 3) with
only those neurocognitive measures that showed moderate to
strong effect sizes (i.e. effect size >0.70; see Table 2). In
Model 3, LT average drinks, age and AMNART, CVLT-II
Immediate, Short and Long Delayed Free Recall and
WAIS-III Digit Symbol were simultaneously entered. Model
3 was signiﬁcant [χ
2 (6)=53.2, P <0.001, r
2 =0.61],
accounted for 61% of the variance, accurately classiﬁed 80%
of nsALC and 89% of sALC into their respective groups,
with an overall classiﬁcation accuracy of 85%. However,
relative to Model 2, Model 3 showed a lower overall classiﬁ-
cation accuracy (85 vs. 91%). Additionally, Model 3 did not
demonstrate a signiﬁcant reduction in residual error relative
to Model 2 [χ
2 (7)=8.1, P>0.50], indicating that Model 3
did not provide a more accurate ﬁt of the data. Discriminant
analysis with the same predictors as Model 3 was also sig-
niﬁcant [χ
2 (6)=52.4, P <0.001], but also resulted in a less
accurate prediction of the group membership compared
with the original discriminant analysis model (see above),
with 82% of non-smokers and 78% of smokers correctly
classiﬁed.
Factor analysis of the 11 neurocognitive measures used
as predictors in the above logistic regression and discrimi-
nant analyses resolved into three components. Trails A,
Stroop Color and Color-Word and WAIS-III Digit symbol,
Symbol Search and Picture Completion showed high load-
ings on Component 1; CVLT-II Immediate Recall, Short
and Long Delayed Free Recall showed high loadings on
Component 2; BVMT-R Total and Delayed Recall had
high loadings on Component 3. Thus, the factor analysis
suggests that the principal indices are processing speed,
auditory–verbal learning/memory and visuospatial learning/
memory.
Relationships between smoking chronicity and individual
cognitive measures in smoking ALC
After controlling for LT average drinks per month, greater
LT number of years of smoking in sALC was signiﬁcantly
related to lower scores on 13 of 27 measures (Table 3).
Additionally, greater LT number of years of smoking was
signiﬁcantly associated with lower scores on 10 of 11 neu-
rocognitive measures where sALC demonstrated signiﬁ-
cantly lower performance than nsALC. Conversely, after
controlling for LT number of years of smoking, LT
average drinks per month was related to 3 of 27 measures
and was not related to any measures that discriminated
sALC from nsALC.
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The main ﬁndings from this cohort of 92 predominantly
Caucasian male US Armed Services Veterans seeking treat-
ment for alcohol dependence were as follows: (a) sALC per-
formed signiﬁcantly worse than nsALC on 11 of 27 standard
clinical and research neurocognitive measures; (b) using two
independent methods, the combination of these 11 measures
robustly predicted smoking status and demonstrated high
sensitivity and speciﬁcity in group classiﬁcation, while con-
trolling for the inﬂuence of age, estimated premorbid intelli-
gence and LT alcohol consumption; (c) the 11 measures
appear to primarily represent indices of processing speed,
auditory–verbal and visuospatial learning and memory; (d)
greater smoking chronicity in sALC was related to poorer
performance on multiple measures after controlling for LT
alcohol consumption.
The 11 measures assessing learning, memory and proces-
sing speed demonstrated high sensitivity and speciﬁcity in
the prediction the smoking status as well as medium to large
effect sizes for mean differences between sALC and nsALC
during early abstinence from alcohol. These results extend
our previous work by identifying the speciﬁc measures
within a comprehensive battery of commonly used clinical
and research tests that accurately and robustly discriminated
smokers from non-smokers with alcohol dependence. The
ﬁndings from this study are also consistent with earlier work
(e.g. Durazzo et al., 2006b, 2008; Glass et al., 2006) demon-
strating that chronic smoking in AUDs does not appear to
adversely affect all domains of neurocognition. Previous neu-
roimaging studies in this cohort at ~1-month of abstinence
showed lower frontal gray matter perfusion and lower
N-acetylaspartate level (NAA; marker of neuronal integrity)
in the frontal white matter, lower NAA and choline-
containing compounds (Cho; marker of membrane synthesis/
turnover) in mesial temporal/hippocampal subregions and
lower hippocampal volume in sALC compared with nsALC
(Durazzo et al., 2006a; Gazdzinski et al., 2008; Mon et al.,
2009). These regional neuroimaging ﬁndings provide a
potential neurobiological basis for the general pattern of per-
formance demonstrated by sALC and nsALC as well as for
the ability of indices of learning, memory and processing
speed to accurately predict smoking status in this alcohol-
dependent cohort during early abstinence. See Durazzo and
Meyerhoff (2007) for review of the mechanisms by which
chronic cigarette smoking may adversely affect neurobiology
and neurocognition in AUDs.
It is noteworthy that the performance on measures gener-
ally fell in the average range of functioning or higher for
both nsALC and sALC, with the exception of the Grooved
Pegboard, Short Categories Test and Luria Item 99, which
were all in the low average range for both groups. These
ﬁndings are consistent with our earlier work (see Durazzo
et al., 2006b, 2008) and congruent with the observation that
only 50% of individuals with AUDs exhibit clinically signiﬁ-
cant neurocognitive dysfunction after 2–3 weeks of absti-
nence from alcohol (Rourke and Loberg, 1996). This
highlights the considerable variability in the vulnerability/
resiliency to the effects of AUDs, which may be inﬂuenced
by such factors as chronic smoking, psychiatric disorders,
medical comorbidities and genetic predispositions. The
associations of poorer performance on multiple age-adjusted
Table 3. Partial correlations between lifetime number of years of smoking, lifetime average drinks per month and individual measure z-scores in sALC
(n=56)
Measure Lifetime number of years of smoking
a Lifetime average drinks per month
b
AMNART −0.04 −0.41**
BVMT-R Total Recall −0.41** −0.02
BVMT-R Delayed Recall −0.38** 0.03
CVLT-II Immediate Recall (trials 1-5) −0.29* −0.08
CVLT-II Short Delayed Free Recall −0.38** 0.02
CVLT-II Long Delayed Free Recall −0.27* −0.03
Grooved Peg Board Dominant Hand −0.20 −0.07
Grooved Peg Board Non-Dominant Hand −0.23 0.01
Luria Item 99 −0.38** −0.16
Short Categories Test −0.30* −0.24
Stroop Word −0.17 −0.09
Stroop Color −0.14 −0.23
Stroop Color-Word −0.26* −0.01
Trail Making Test, part A −0.38** −0.02
Trail Making Test, part B −0.25 −0.07
WAIS-III Arithmetic −0.16 −0.36**
WAIS-III Block Design −0.29* −0.08
WAIS-III Digit Span −0.12 −0.18
WAIS-III Digit Symbol −0.17 −0.20
WAIS-III Information −0.09 −0.24
WAIS-III Picture Completion −0.39** −0.20
WAIS-III Similarities −0.13 −0.32*
WAIS-III Symbol Search −0.29* −0.18
WCST-64 Total Errors −0.19 −0.04
WCST-64 Perseverative Responses −0.26* −0.23
WCST-64 Perseverative Errors −0.24 −0.20
WCST-64 Non-Perseverative Errors −0.11 −0.14
Note: Asterisks indicate significant two-tailed tests *P≤0.05, **P≤0.01.
aControlled for lifetime average drinks per month.
bControlled for lifetime number of years of smoking.
Prediction of Smoking Status in Alcohol Dependence 511measures with longer smoking duration after controlling for
alcohol consumption in sALC converges with our previous
work (Durazzo et al., 2006b) as well as with Glass et al.
(2009) who found that higher pack years was related to
poorer performance on components of the Trail Making and
Stroop Tests in a large community-recruited cohort of AUD
participants. Additionally, our neuroimaging ﬁndings in this
cohort (Durazzo et al., 2004, 2006a) showed higher cigarette
consumption was associated with lower thalamic and lenticu-
lar nuclei NAA levels and lower frontal and parietal white
matter Cho levels in sALC during early recovery. Overall,
these ﬁndings suggest that the direct and/or indirect effects
of chronic smoking place an additional burden on neuro-
cognitive function in AUD or compound a potentially pre-
existing vulnerability in smoking AUD.
This report has limitations that may inﬂuence the general-
izability of the ﬁndings. We did not assess for personality
disorders, which may contribute to the neurocognitive and
neurobiological abnormalities observed in AUD (Costa
et al., 2000; Eckardt et al., 1995; Giancola and Moss, 1998;
Kuruoglu et al., 1996). The results were also potentially inﬂu-
enced by other factors not directly assessed in this study, such
as nutrition, exercise and previous exposure to environmental
cigarette smoke or premorbid/genetic predispositions. The
majority of participants were males recruited from the
San Francisco VA Medical Center, which did not allow for
the examination of the potential effects of sex on neurocogni-
tion. Future research comparing smoking and non-smoking
AUDs on tasks speciﬁcally assessing decision making, risk
taking and impulsivity is warranted because such measures
have been reported to be adversely affected by AUD and
chronic cigarette smoking (Bobova et al., 2009; Fein et al.,
2006; Lejuez et al., 2003; Li et al., 2009). Assessment of
decision-making, risk taking and impulsivity is critical for
understanding the full scope of the neurocognitive conse-
quences associated with chronic smoking in AUD.
In summary, an estimated 60–90% of individuals seeking
treatment for AUD in North America are chronic cigarette
smokers (Durazzo and Meyerhoff, 2007; Room, 2004).
Chronic cigarette smoking is a modiﬁable health risk that is
associated with at least 440,000 deaths in the USA alone,
with increasing mortality among individuals with AUD, sub-
stance use disorders and other neuropsychiatric conditions
(see Durazzo and Meyerhoff, 2007 for review). These results
offer treatment providers additional psychoeducational infor-
mation on the consequences of chronic smoking in
treatment-seeking AUD samples. Evidence from this report,
combined with our earlier neurocognitive and neuroimaging
studies (Durazzo and Meyerhoff, 2007; Mon et al., 2009) and
the high mortality associated with cigarette smoking in
AUD (Hurt et al., 1996), lend strong support to the growing
clinical movement (which is a routine practice at the San
Francisco VA Medical Center) to make smoking cessation
programs available to chronic smokers entering treatment for
substance use disorders.
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